Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.
Zimmer Biomet Holdings's quarterly accumulated depreciation
declined
from Dec. 2025 (CHF-4,025 Mil) to Mar. 2026 (CHF-4,010 Mil) but then
increased
from Mar. 2026 (CHF-4,010 Mil) to Jun. 2026 (CHF-4,142 Mil).
Zimmer Biomet Holdings's annual accumulated depreciation
increased
from Dec. 2023 (CHF-4,070 Mil) to Dec. 2024 (CHF-4,138 Mil) but then
stayed the same
from Dec. 2024 (CHF-4,138 Mil) to Dec. 2025 (CHF-4,025 Mil).
Zimmer Biomet Holdings Accumulated Depreciation Related Terms
Zimmer Biomet Holdings Accumulated Depreciation Historical Data
* Premium members only.
The historical data trend for Zimmer Biomet Holdings's Accumulated Depreciation can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.
What does a Accumulated Depreciation of CHF-4,142 Mil mean?
Zimmer Biomet Holdings (XSWX:ZBH) has a Accumulated Depreciation of CHF-4,142 Mil as of Jun. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Zimmer Biomet Holdings and its competitors.
Is Zimmer Biomet Holdings' Accumulated Depreciation too high?
Zimmer Biomet Holdings' current Accumulated Depreciation is CHF-4,142 Mil. Overall, Zimmer Biomet Holdings has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Accumulated Depreciation compare to STE and PEN?
Zimmer Biomet Holdings' Accumulated Depreciation of CHF-4,142 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Medical Devices & Instruments company?
A good Accumulated Depreciation depends on the Medical Devices & Instruments industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Zimmer Biomet Holdings and its competitors. Zimmer Biomet Holdings's current Accumulated Depreciation is CHF-4,142 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Zimmer Biomet Holdings (XSWX:ZBH) has a current Accumulated Depreciation of CHF-4,142 Mil. The stock's GF Value™ is CHF99.51, compared to a current price of CHF80.50 — trading 19.1% below its estimated fair value. The current Accumulated Depreciation is CHF-4,142 Mil. Zimmer Biomet Holdings' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current Accumulated Depreciation is CHF-4,142 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?
Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued.
The current stock price of CHF80.50 is trading 19.1% below its estimated GF Value™ of CHF99.51.
Key valuation signals for XSWX:ZBH:
Accumulated Depreciation: CHF-4,142 Mil
GF Value™: CHF99.51 vs. price of CHF80.50 (19.1% below fair value)
No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
68GF Score
Get the complete analysis for XSWX:ZBH
Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ZBH has been successfully added to your 
